Browse
Author
Showing results 1 to 1 of 1
Issue Date | Title / Author(s) / Citation | File | Altmetrics |
---|---|---|---|
2017-08 | A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer Targeted Oncology, Vol.12 No.4, pp.463-474 | DOI |
1